AI filing briefs

Aclarion, Inc. (ACON)

ACON 8-K filings, explained

Every material Form 8-K Aclarion, Inc. has filed with the SEC since January 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs on record3since Jan 13, 2026
Latest filingApr 22, 2026shareholder
High impact (4-5)1of 3 briefs
ToneMixed1Neutral2
shareholder 2financing 1

2026

Apr 22, 9:00 AM ET

Aclarion Authorizes Up to $2.5 Million Share Repurchase Program Over 12 Months

Neutral shareholder Written later 8.01

Aclarion's board authorized a share repurchase program of up to $2.5 million of its outstanding common stock, to be executed over the next 12 months. The company said it intends to fund the program from existing cash, which it reported at approximately $19.0 million as of March 31, 2026.

  • Board approved the program on April 21, 2026; press release issued April 22, 2026
  • Repurchases of up to $2.5 million may be made over the next 12 months, through methods including open market purchases and 10b5-1 plans
  • No obligation to buy any specific number of shares; program may be modified, suspended or discontinued at any time
  • Cash and cash equivalents were approximately $19.0 million as of March 31, 2026
Read the filing on SEC.gov ↗
Mar 19, 4:15 PM ET

Aclarion adopts one-year stockholder rights plan with $14.00 exercise price

Neutral shareholder Written later 1.013.035.038.01

Aclarion's board adopted a limited duration stockholder rights plan on March 19, 2026, declaring a dividend of one right per common share and per Rights-Eligible Warrant to holders of record on March 30, 2026. The rights become exercisable only if a person or group acquires 10% or more of common stock without board approval, and the plan expires on March 18, 2027. The company states it was not adopted in response to any specific acquisition proposal, but the plan could make an unsolicited takeover more costly for a bidder.

  • Rights are exercisable at $14.00 per right, to buy one one-thousandth of a share of Series D Junior Participating Preferred Stock.
  • Rights become exercisable if a person or group acquires 10% or more of common stock in a transaction not approved by the Board.
  • Record date is March 30, 2026; the plan expires March 18, 2027, unless redeemed, exchanged or terminated earlier.
  • Board may redeem the rights at $0.001 per right; rights agent is VStock Transfer, LLC.
Read the filing on SEC.gov ↗
Jan 13, 9:00 AM ET

Aclarion closes $10.4 million stock sale at $5.18 per share, reports $21.6 million cash

Mixed financing Written later 7.01

Aclarion closed a registered direct offering that the company says raised $10.4 million at $5.18 per share, which it describes as leaving it with zero debt and cash runway into 2028. The sale adds new shares and pre-funded warrants to the share count, so existing shareholders will hold a smaller percentage of the company.

  • Offering closed January 9, 2026, per the January 13, 2026 press release.
  • Filing describes 200,000 common shares at $5.18 per share, plus pre-funded warrants for up to 1,800,000 shares.
  • As of January 12, 2026, the company reported $21.6 million in cash and zero debt.
  • Company says cash runway now extends into 2028 based on current operating plans.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Aclarion, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →